Marksans Pharma Limited

Marksans Pharma Ltd is a Mumbai-based global pharmaceutical company engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. Serving regulated and semi-regulated markets, the company operates across key geographies including North America, Europe, Australia, and emerging markets. Marksans specializes in solid oral, liquid oral, ointments, and topical preparations, offering products spanning therapeutic categories such as analgesics, antidiabetics, antibiotics, cough & cold remedies, cardiovascular agents, and gastrointestinal medications.

With over two decades of operational expertise, Marksans Pharma operates state-of-the-art manufacturing facilities in India and the UK, approved by regulatory authorities including the US FDA, MHRA (UK), TGA (Australia), and others. The company focuses on compliance-driven, cost-effective production, supported by robust R&D capabilities aimed at developing differentiated generic and value-added products. As of 2025, Marksans has an established presence via both own-label and contract manufacturing arrangements, supplying to leading global pharmaceutical retailers and distributors.